- call +1-201-465-4211
- email sales@mrinsights.biz
Exosomes are cell-derived vesicles that are present in many and perhaps all eukaryotic fluids, including blood, urine, and cultured medium of cell cultures. A sub-type of exosomes, defined as matrix-bound nanovesicles (MBVs), was reported to be present in extracellular matrix (ECM) bioscaffolds (non-fluid). The reported diameter of exosomes is between 30 and 100 nm, which is larger than low-density lipoproteins (LDL) but much smaller than, for example, red blood cells. Exosomes are either released from the cell when multivesicular bodies fuse with the plasma membrane or released directly from the plasma membrane.
Scope of the Report:
This report focuses on the Exosome Diagnostic and Therapeutics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The exosome diagnostic and therapeutics market in North America is estimated to reach a high market valuation by end of 2027 and is projected to grow at a significant rate throughout the period of assessment.
The worldwide market for Exosome Diagnostic and Therapeutics is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Thermo Fisher
NanoSomix
NX PHARMAGEN
Malvern
Capricor
Exosome
Exiqon
System Biosciences
Aegle
AMS
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Instrument
Software
Reagents and Kits
Market Segment by Applications, can be divided into
Hospitals
Cancer Institutes
Diagnostic Centres
Others
There are 15 Chapters to deeply display the global Exosome Diagnostic and Therapeutics market.
Chapter 1, to describe Exosome Diagnostic and Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Exosome Diagnostic and Therapeutics, with sales, revenue, and price of Exosome Diagnostic and Therapeutics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Exosome Diagnostic and Therapeutics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Exosome Diagnostic and Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Exosome Diagnostic and Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Exosome Diagnostic and Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Instrument
1.2.2 Software
1.2.3 Reagents and Kits
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Cancer Institutes
1.3.3 Diagnostic Centres
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher
2.1.1 Business Overview
2.1.2 Exosome Diagnostic and Therapeutics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Thermo Fisher Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 NanoSomix
2.2.1 Business Overview
2.2.2 Exosome Diagnostic and Therapeutics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 NanoSomix Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 NX PHARMAGEN
2.3.1 Business Overview
2.3.2 Exosome Diagnostic and Therapeutics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 NX PHARMAGEN Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Malvern
2.4.1 Business Overview
2.4.2 Exosome Diagnostic and Therapeutics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Malvern Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Capricor
2.5.1 Business Overview
2.5.2 Exosome Diagnostic and Therapeutics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Capricor Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Exosome
2.6.1 Business Overview
2.6.2 Exosome Diagnostic and Therapeutics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Exosome Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Exiqon
2.7.1 Business Overview
2.7.2 Exosome Diagnostic and Therapeutics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Exiqon Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 System Biosciences
2.8.1 Business Overview
2.8.2 Exosome Diagnostic and Therapeutics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 System Biosciences Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Aegle
2.9.1 Business Overview
2.9.2 Exosome Diagnostic and Therapeutics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Aegle Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AMS
2.10.1 Business Overview
2.10.2 Exosome Diagnostic and Therapeutics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AMS Exosome Diagnostic and Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Exosome Diagnostic and Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Exosome Diagnostic and Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Exosome Diagnostic and Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Exosome Diagnostic and Therapeutics Manufacturer Market Share in 2017
3.3.2 Top 6 Exosome Diagnostic and Therapeutics Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Exosome Diagnostic and Therapeutics Market Analysis by Regions
4.1 Global Exosome Diagnostic and Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Exosome Diagnostic and Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Exosome Diagnostic and Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
5 North America Exosome Diagnostic and Therapeutics by Countries
5.1 North America Exosome Diagnostic and Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Exosome Diagnostic and Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Exosome Diagnostic and Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Exosome Diagnostic and Therapeutics by Countries
6.1 Europe Exosome Diagnostic and Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Exosome Diagnostic and Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Exosome Diagnostic and Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Exosome Diagnostic and Therapeutics by Countries
7.1 Asia-Pacific Exosome Diagnostic and Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Exosome Diagnostic and Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Exosome Diagnostic and Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
8 South America Exosome Diagnostic and Therapeutics by Countries
8.1 South America Exosome Diagnostic and Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Exosome Diagnostic and Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Exosome Diagnostic and Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Exosome Diagnostic and Therapeutics by Countries
9.1 Middle East and Africa Exosome Diagnostic and Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Exosome Diagnostic and Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Exosome Diagnostic and Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Exosome Diagnostic and Therapeutics Sales and Growth Rate (2013-2018)
10 Global Exosome Diagnostic and Therapeutics Market Segment by Type
10.1 Global Exosome Diagnostic and Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Exosome Diagnostic and Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Exosome Diagnostic and Therapeutics Revenue and Market Share by Type (2013-2018)
10.2 Instrument Sales Growth and Price
10.2.1 Global Instrument Sales Growth (2013-2018)
10.2.2 Global Instrument Price (2013-2018)
10.3 Software Sales Growth and Price
10.3.1 Global Software Sales Growth (2013-2018)
10.3.2 Global Software Price (2013-2018)
10.4 Reagents and Kits Sales Growth and Price
10.4.1 Global Reagents and Kits Sales Growth (2013-2018)
10.4.2 Global Reagents and Kits Price (2013-2018)
11 Global Exosome Diagnostic and Therapeutics Market Segment by Application
11.1 Global Exosome Diagnostic and Therapeutics Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Cancer Institutes Sales Growth (2013-2018)
11.4 Diagnostic Centres Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Exosome Diagnostic and Therapeutics Market Forecast (2018-2023)
12.1 Global Exosome Diagnostic and Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Exosome Diagnostic and Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Exosome Diagnostic and Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Exosome Diagnostic and Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Exosome Diagnostic and Therapeutics Market Forecast (2018-2023)
12.2.4 South America Exosome Diagnostic and Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Exosome Diagnostic and Therapeutics Market Forecast (2018-2023)
12.3 Exosome Diagnostic and Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Exosome Diagnostic and Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Exosome Diagnostic and Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Exosome Diagnostic and Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Exosome Diagnostic and Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Exosome Diagnostic and Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Exosome Diagnostic and Therapeutics Picture
Table Product Specifications of Exosome Diagnostic and Therapeutics
Figure Global Sales Market Share of Exosome Diagnosti
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
